At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 10 enrolled
Drug / intervention
Kava Dietary Supplementdrug
Likely dose
Kava Dietary Supplement 75mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics
In Brief
A Phase 1 clinical trial evaluating Kava Dietary Supplement for Pharmacokinetics. Completed, enrolled 10 participants across 1 site.
Detailed Summary
Kava is a dietary supplement on the US market and is experiencing a resurgence of its use. Its pharmacokinetic information, however, is lacking which is important for its future effective usage as a dietary supplement or potentially as a botanical therapeutics. This phased trial, based on the recommendation from NIH, is to collect pharmacokinetic data of kava in healthy subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPharmacokinetics
CountriesUnited States
Timeline
Phase 1CompletedFinished
20192020202120222023202420252026
First PostedFeb 2019
Enrollment StartFeb 2020
Primary CompletionApr 2021
Study CompletionJul 2021
TodayJul 2026
First PostedFeb 18, 2019
Enrollment StartFeb 26, 2020
Primary CompletionApr 21, 2021
Study CompletionJul 13, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.4 years ago
Interventions
Kava Dietary Supplementdrug
Participants will be given three 75mg kava capsules.